Sanofi Opens $925-Million Flu Vaccine Facility in Toronto
Sanofi’s new Charles Best Building adds end-to-end flu vaccine manufacturing in Toronto, with production planned for 2027 pending approval.
Sanofi’s new Charles Best Building adds end-to-end flu vaccine manufacturing in Toronto, with production planned for 2027 pending approval.